• Vivus Inc., of Mountain View, Calif., reported net product revenues of $41,000 from prescriptions of newly approved obesity drug Qsymia (phentermine/topiramate) shipped from certified pharmacies to patients. The drug, approved in July, was made available starting Sept. 17.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter